Global News

Soligenix initiates phase 1 study of SGX203 for pediatric Crohn's disease

Thursday, May 16, 2013 08:00 AM

Soligenix, a clinical stage biopharmaceutical company focused on inflammatory diseases and biodefense countermeasures, has initiated the first clinical study for development of SGX203 (oral beclomethasone 17, 21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease. The program has previously received Fast Track and Orphan Drug designations from the FDA for oral BDP as a treatment for pediatric Crohn's disease.

More... »

Vince & Associates Clinical Research acquired by the Altasciences Group

Wednesday, May 15, 2013 01:40 PM

The Altasciences Group of Quebec has acquired Vince & Associates Clinical Research.

More... »

Sorrento, Igdrasol acquire E.U. distribution rights to Cynviloq from Samyang

Wednesday, May 15, 2013 12:46 PM

Sorrento Therapeutics, a development-stage biopharmaceutical company, and Igdrasol, a developer of personalized paclitaxel, have acquired exclusive distribution rights from Samyang Biopharmaceuticals, a South Korean corporation, to Cynviloq (marketed as Genexol-PMR in South Korea) in the 27 countries of E.U.

More... »

Cobra Biologics, Vaccibody to manufacture DNA vaccine

Wednesday, May 15, 2013 12:21 PM

Cobra Biologics, an international clinical and commercial manufacturer of biologics and pharmaceuticals, and Vaccibody, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, have signed an agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies, such as precancerous lesions found in cervical cancer.

More... »

Adaptive, BMS ink biomarker discovery collaboration agreement

Wednesday, May 15, 2013 11:57 AM

Adaptive Biotechnologies, a Seattle-based developer of next generation sequencing assays, has entered into a collaboration agreement with Bristol-Myers Squibb for the discovery of immunological biomarkers in oncology.

More... »

Astellas outlines plan to reshape its research framework, reallocate resources

Tuesday, May 14, 2013 02:44 PM

Tokyo-based Astellas Pharma has announced plans to reshape its research framework by introducing new initiatives to enhance the ability to generate innovative drugs.

More... »

Certara, Veristat partner for combined service offerings

Tuesday, May 14, 2013 01:37 PM

Certara, a provider of software and scientific consulting services from drug discovery through clinical development, and Veristat, a full-service CRO, have formed an alliance to offer combined services to their clients.

More... »

BIO, ViS Research Institute target pediatric trials

Tuesday, May 14, 2013 01:27 PM

The Biotechnology Industry Organization and the ViS Research Institute have launched an initiative aimed at improving the efficiency of clinical development for pediatric therapeutics. BIO and its member companies will work with ViS to use its online analytics platform to evaluate global pediatric clinical research infrastructure, identify pediatric patient populations and empower clinical research collaboration.

More... »

Datatrak partners with Stat Research

Tuesday, May 14, 2013 01:24 PM

Datatrak International, a developer of cloud-based, unified eClinical technologies and related services, has partnered with Stat Research, a medically-driven CRO based in Argentina that provides research services in Latin America.

More... »

SCRS establishes strategic alliance with Brazilian Society of Investigators

Tuesday, May 14, 2013 01:19 PM

The Society for Clinical Research Sites (SCRS) has formed a strategic alliance with Dr. Luis Augusto Russo, president of the Brazilian Society of Investigators, launched in 2007. Its current membership of 300 is comprised mostly of principal investigators and owners of private sites across Latin America.

More... »